Virtu Financial LLC E Ffector Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
BUY
$0.35 - $1.39 $3,549 - $14,094
10,140 New
10,140 $8,000
Q2 2022

Aug 09, 2022
BUY
$1.3 - $3.84 $20,367 - $60,161
15,667 New
15,667 $22,000
Q4 2021

Feb 17, 2022
SELL
$5.71 - $13.15 $99,605 - $229,388
-17,444 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.56 - $27.17 $149,320 - $473,953
17,444 New
17,444 $245,000

Others Institutions Holding EFTR

# of Institutions
6
Shares Held
6.53M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email